Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Titel:
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Auteur:
Durie, Brian G M Hoering, Antje Abidi, Muneer H Rajkumar, S Vincent Epstein, Joshua Kahanic, Stephen P Thakuri, Mohan Reu, Frederic Reynolds, Christopher M Sexton, Rachael Orlowski, Robert Z Barlogie, Bart Dispenzieri, Angela